Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Kyma Medical entertains $35m acquisition offer
Kyma Medical Technologies, a developer of remote cardiac monitoring devices, is entertaining a $35 million acquisition offer from an unnamed suitor, according to a regulatory filing by Elron Electronic Industries, which owns a stake in Kyma.
Kyma told Elron that it inked a non-binding letter of intent with “a non-affiliated 3rd party regarding a potential acquisition of Kyma” for $35 million in cash, plus a 41/2-year earnout schedule for an unspecified series of revenue-based milestones, according to the filing. The deal would also include sales royalties for 51/2 years, Elron said, noting that it would net about $7 million if the deal is consummated. Read more
2. TransMedics raises $20m for ‘heart-in-a-box’
TransMedics raised a $20 million funding round for its organ preservation and transportation device, according to a regulatory filing.
Eleven unnamed investors participated in the round for Andover, Mass.-based TransMedics, according to the filing. Read more
1. New JenaValve CEO is Boston Scientific vet Carr-Brendel
JenaValve said that it tapped Victoria Carr-Brendel, former general manager of Boston Scientific’s Bayer Interventional business, as its new chief executive officer.
Carr-Brendel will replace Jan Keltjens, who served as interim CEO of the transcatheter aortic valve repair-focused company since January 2015. Keltjens will remain with the company as chairman of the board, JenaValve said. Read more
The post MassDevice.com +3 | The top 3 medtech stories for June 8, 2015 appeared first on MassDevice.
from MassDevice http://ift.tt/1F4Ionr
Cap comentari:
Publica un comentari a l'entrada